5-Aminolevulinic acid photodynamic therapy of transplantable colon adenocarcinoma in BALB/c mice

Archivum Immunologiae et Therapiae Experimentalis

Volumn 46, Issue 5, 1998, Pages 301-304

  Ziółkowski, Piotr ^a   Symonowicz, Krzysztof ^a   Osiecka, Beata J ^a   Rabczyński, Jerzy ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

5 Aminolevulinic acid; Colon adenocarcinoma; Photodynamic therapy; Protoporphyrin IX concentration

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ADENOCARCINOMA; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER TRANSPLANTATION; COLON CARCINOMA; FEMALE; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; TREATMENT OUTCOME; TUMOR NECROSIS;

AMINOLEVULINIC ACID; ANIMALS; COLONIC NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 0031770912     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. ABELS C., HEIL P., DELLIAN M., KUHNLE G. E. H., BAUMGARTNER R. and GOETZ A. E. (1994): In vivo kinetics and spectra of 5-aminolevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster. Br. J. Cancer, 70, 826 - 833.
2. BAUMGARTNER R., HUBER R. M., SCHULZ H., STEPP H., RICK K., GAMARRA F., LEBERIG A. and ROTH C. (1996): Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J. Photochem. Photobiol. B: Biol. 36, 169 - 174.
3. BEDWELL J., MACROBERT A. J., PHILLIPS D. and BOWN S. G. (1992): Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumour model. Br. J. Cancer, 65, 818 - 824.
4. DOUGHERTY T. J. (1984): Photodynamic therapy (PDT) of malignant tumors, Crit. Rev. Oncol. Hematol., 2, 83 - 116.
5. EL-FAR M., GHONEIM M. and IBRAHIM E. (1990): Biodistribution and selective in vivo tumor localization of endogenous porphyrins induced and stimulated by 5-aminolevulinic acid: a newly developed technique. J. Tumor Marker Oncol., 5, 27 - 34.
6. FIJAN S., HOENIGSMANN H. and ORTEL B. (1995): Photodynamic therapy of epithelial skin tumors using delta-aminolevulinic acid and desferrioxamine. Br. J. Dermatol., 133, 282 - 288.
7. 14C hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res., 39, 146 - 151.
8. HUA Z., GIBSON S. L., FOSTER T. H. and HILF R. (1995): Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res., 55, 1723 - 1731.
9. KENNEDY J. C., POTTIER R. H. and PROSS D. C. (1990): Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol., 6, 143 - 148.
10. KREIMER-BIRNBAUM M. (1989): Modified porphyrins, chlorins, phthalocyanines and purpurines: Second generation photosensitizers for photodynamic therapy. Semin. Hematol., 26, 157 - 173.
11. LOH C. S., MACROBERT A. J., BEDWELL J., REGULA J., KRASNER N. and BOWN S. G. (1993): Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br. J. Cancer, 68, 41 - 51.
12. MALIK Z., KOSTENICH G., ROITMAN L., EHRENBERG B. and ORENSTEIN A. (1995): Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol. B: Biol., 28, 213 - 218.
13. PENG Q., MOAN J., WARLOE T., NESLAND J. M. and RIMINGTON C. (1992): Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer, 52, 433 - 443.
14. PENG Q., WARLOE T., MOAN J., STEEN H., GIERCKSKY K.-E, and NESLAND J. M. (1993): Localization of ALA-induced porphyrins in normal and malignant tissues of mice, dogs and patients. Conference on photosensitization and photochemotherapy of cancer, March, 16 - 17, Oslo. Abstract book, p S4.
15. REGULA J., RAVI B., BEDWELL J., MACROBERT A. J. and BOWN S. G. (1994): Photodynamic therapy using 5-aminolevulmic acid for experimental pancreatic cancer-prolonged animal survival. Br. J. Cancer, 70, 248 - 254.
16. RIMINGTON C. (1971): Quantitativ determination of porphobilinogen and porphyrins in urine and porphyrins in faeces and erythrocytes. Assoc. Clin. Pathol. Broadsheet, 70, 1 - 9.
17. SCHUITMAKER J. J., BAAS P. VAN LEENGOED H. L L. M., VAN DER MEULEN F. W., STAR W. M. and VAN ZANDWIJK N. (1996): Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B: Biol., 34, 3 - 12.
18. SROKA R., BEYER W., GOSSNER L., SASSY T., STOCKER S. and BAUMGARTNER R. (1996): Pharmacokinetics of 5-aminolevulinic acid-induced porphyrins in tumour-bearing mice. J. Photochem. Photobiol. B: Biol., 34, 13 - 19.
19. STENZL A., EDER L., KOSTRON H., KLOCKER H. and BARTSCH G. (1996): Electromotive diffusion (EMD) and photodynamic therapy with δ-aminolaevulinic acid (δ-ALA) for superficial bladder cancer. J. Photochem. Photobiol. B: Biol., 36, 233 - 236.
20. SZEIMIES R-M., CALZAVARA-PINTON P. G., KARRER S., ORTEL B. and LANDTHALER M. (1996): Topical photodynamic therapy in dermatology. J. Photochem. Photobiol. B: Biol., 36, 213 - 219
21. 1. Patol. Pol., 30, 457 - 474.